Vasoconstriction, decreased expression of vascular endothelial growth factor and β-fibroblast growth factor genes, and triggering apoptosis in capillary endothelial cells are among propranolol’s proposed mechanisms of action in regressing hemangiomas [12,13]. Here, VEGFA is linked to hemangioma.